Food testing firm announces acquisition
Published:  19 March, 2014

Synergy Health has acquired food allergen testing and authentication company Genon Laboratories, as it looks to extend its services across Europe and beyond.

Yorkshire-based Genon undertook more than 25% of all the authentication tests carried out during the 2013 horsemeat scandal. Its services are widely used across the UK’s food manufacturing, processing and retail industries.

According to Synergy, it has also taken the lead in the application of polymerase chain reaction (PCR) testing, used for proving the DNA content of foods. Having developed its own PCR test techniques, the firm was in a position to respond immediately during the alarm that followed the discovery of horsemeat in UK supermarkets last year.

Synergy, a global provider of outsource clinical services, said it intended to invest in further developing Genon’s test technologies in the UK and extend its highly specialised services.

Angela Bromley, general manager, Genon, said: “Becoming part of Synergy Health means we will have the investment to create a global presence. We aim to keep, and further develop, our specialist focus for UK customers, but also take our services to much wider markets, including the establishment of laboratory facilities in mainland Europe. The overseas market has plenty of scope for growth and we are very excited about the possibilities.”

Genon was formed in 2006 by Manchester University molecular biologist and geneticist, Dr Mike Bromley, and microbiologist Dr Mike Birch.